November 14, 2019 — The results of the 21 late-breaking clinical trials presented for the first time at Vascular Interventional Advances (VIVA) 2019 conference. These results were presented in four ...
Stents Peripheral
Peripheral stents are used to open narrow and hardening arteries that supply blood to the legs and feet.
-
-
November 7, 2019 — Although the Abbott Absorb fully bioresorbable drug-eluting stent (DES) was taken off the market due to poor sales and questions on outcomes in coronary vessels compared to ...
-
The U.S. Food and Drug Administration (FDA) released an updated MedWatch Alert this month on the safety of paclitaxel-coated devices used to treat peripheral artery disease (PAD) following its review of long-term follow-up clinical data. The agency said five-year results from three randomized trials showed an increased mortality rate in patients treated with these devices compared to those treated with uncoated devices. While these data provide reason for caution, the FDA noted that the devices still provide documented short-term benefits, and healthcare providers should consider all options for their PAD patients.
-
April 15, 2019 – Intact Vascular Inc. received U.S. Food and Drug Administration (FDA) market clearance for the Tack Endovascular System. This is a purpose-built dissection repair device implanted ...
May 30, 2024 — Biotronik announced the presentation of the 12-month results from the BIONETIC-I study this week at LINC ...
May 30, 2024
February 14, 2024 — Efemoral Medical, developer of advanced interventional bioresorbable therapies, today announced that ...
February 14, 2024
February 16, 2023 — Northeast Scientific Inc., the pioneers in reprocessing single use peripheral vascular catheters ...
February 16, 2023
October 11, 2022 — Efemoral Medical, developer of advanced interventional bioresorbable therapies, announced that it ...
October 11, 2022
August 23, 2022 — The first US patient has been enrolled in the FDA SELUTION4BTK (Below-the-Knee) clinical trial ...
August 23, 2022
February 22, 2021 — The U.S. Food and Drug Administration (FDA) recently cleared the Cook Medical Zilver Vena Venous ...
February 22, 2021
December 16, 2020 — Efemoral Medical announced the first-in-human (FIH) use of the its Efemoral bioresorbable vascular ...
December 16, 2020
September 4, 2020 — The U.S. Centers for Medicare and Medicaid Services (CMS) granted a New Technology Add-on Payment ...
September 04, 2020
June 16, 2020 — The 36-month results from Veryan Medical’s MIMICS-2 study for the BioMimics 3D femoropopliteal stent ...
June 16, 2020
Cardiovascular diseases (CVDs) are among the leading causes of death across the globe. For patients suffering from high ...
February 11, 2020
November 11, 2019 — Although common femoral artery (CFA) endarterectomy is still considered the gold standard treatment ...
November 11, 2019
November 7, 2019 — Although the Abbott Absorb fully bioresorbable drug-eluting stent (DES) was taken off the market due ...
November 07, 2019
Feature | Stents Peripheral | Dave Fornell, Editor
November 6, 2019 – The final, long-term, patient-level data for the Cook Medical Zilver PTX drug-eluting stent (DES) ...
November 06, 2019
November 6, 2019 – Boston Scientific announced positive data for two of its devices within the peripheral drug-eluting ...
November 06, 2019
November 14, 2019